Upgrade to SI Premium - Free Trial

Vir Biotechnology Inc. (VIR)

11.39 -0.06 (0.52%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason August 25, 2026 11:07 AM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason August 24, 2026 5:11 PM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: O'Byrne Jason August 21, 2026 3:24 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Aug 11 Filed by: MORE ROBERT J August 12, 2026 2:31 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR) August 10, 2026 6:44 AM - StreetInsider Form SCHEDULE 13G Vir Biotechnology, Inc. Filed by: STATE STREET CORP August 7, 2026 11:11 AM - SEC Filing Vir Biotechnology (VIR) PT Lowered to $25 at Morgan Stanley August 6, 2026 8:53 AM - StreetInsider Vir Biotechnology Inc. (VIR) Tops Q2 EPS by 14c August 5, 2026 5:38 PM - StreetInsider Form 10-Q Vir Biotechnology, Inc. For: Jun 30 August 5, 2026 5:21 PM - SEC Filing Form 8-K Vir Biotechnology, Inc. For: Aug 05 August 5, 2026 4:13 PM - SEC Filing Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results August 5, 2026 4:05 PM - BizWire Form SCHEDULE 13G/A Vir Biotechnology, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC July 31, 2026 11:40 AM - SEC Filing Form 8-K Vir Biotechnology, Inc. For: Jul 20 July 24, 2026 8:32 AM - SEC Filing Vir Biotechnology names interim CFO as O'Byrne departs July 24, 2026 8:30 AM - StreetInsider Vir Biotechnology Announces Chief Financial Officer Transition July 24, 2026 8:30 AM - BizWire Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results July 22, 2026 4:05 PM - BizWire Form 144 Vir Biotechnology, Inc. Filed by: Ramasastry Saira June 29, 2026 3:07 PM - SEC Filing Vir Biotechnology (VIR) PT Raised to $27 at Morgan Stanley June 11, 2026 8:24 AM - StreetInsider Form 4 Vir Biotechnology, Inc. For: Jun 09 Filed by: Coughlin Timothy June 10, 2026 6:21 PM - SEC Filing Form 3 Vir Biotechnology, Inc. For: Jun 09 Filed by: Coughlin Timothy June 10, 2026 6:20 PM - SEC Filing Form 8-K Vir Biotechnology, Inc. For: Jun 09 June 10, 2026 4:28 PM - SEC Filing Vir Biotechnology appoints Timothy Coughlin to board of directors June 10, 2026 4:05 PM - StreetInsider Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors June 10, 2026 4:05 PM - BizWire Full Article List